Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy.

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res. 2007 Dec 01; 67(23):11111-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.